Loading asset research
PolyPid Ltd. Ordinary Shares
PYPDNasdaq · USD · StocksQuote as of · Exchange session not verified$5.15
-0.19%
Today
PYPD
Loading 1D prices…
Market cap
$104.6M
Volume
99.3K
52w high
$5.7352w low
$3.06Company profile
PolyPid Ltd. Ordinary Shares
PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Petah Tikva, Israel, United States
Employees
69
Fiscal year end
1231
CIK
1611842
Session & valuation
Open$5.20
Previous close$5.16
Day high$5.24
Day low$5.04
30-day avg. volume135.6K
Outstanding shares18.2M
Diluted EPS$2.09
Latest annual period
P/E (trailing)2.46
P/E (forward)-4.20
Price / book19.43
Beta1.42
Dividend yield—
Deterministic peer set
Companies with SEC SIC 3841
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| GUTSFractyl Health Inc. Common Stock | $101.9M | $0.00 | — | -$1.86 | -0.47% | Buy |
| MBOTMicrobot Medical Inc. Common Stock | $97.4M | $0.00 | — | -$0.29 | +0.34% | Buy |
| LNSRLENSAR Inc. Common Stock | $93.4M | $51.7M | -66.36% | -$2.87 | -5.59% | Buy |
| SKINSkinHealth Systems Inc. Class A Common Stock | $91.1M | $300.8M | -3.16% | -$0.16 | +1.45% | Sell |
| APYXApyx Medical Corporation Common Stock | $122.2M | $52.8M | -21.22% | -$0.27 | +0.35% | Buy |